From molecules to the capital markets.

Dr George Syrmalis is an MD, PhD-qualified physician-scientist and life sciences investor whose career spans nuclear medicine, radiation immunology, and the global capital markets. He is the Founder and Chief Executive Officer of Bioscience Equity Partners, a licensed investment bank focused exclusively on the life sciences sector, and provides strategic oversight to Antisoma Venture Capital Fund S.A. He also serves as an advisor to the Saudi Biotech Accelerator.

Over the course of more than three decades, he has founded and guided multiple biotechnology companies from early-stage development through to public markets. His work is centred on translating scientific innovation into structured, investable opportunities, with a focus on early-stage biotechnology and medical technology ventures across international markets.

His writing explores the intersection of science, capital formation, and long-term value creation. Further information is available at georgesyrmalis.com.